Further experiments showed that silencing through siRNA increased tumor cell proliferation, while its restoration led to a reduction in proliferation and clonogenicity in vitro and in vivo, suggesting that ATIP3 could be a suitable biomarker and candidate for future targeted therapies [23]. Here, MTUS1 is linked to neoplasm.